Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease: systematic review and meta-analysis

Background - There is a substantial overlap in the epidemiology of chronic hepatitis B (HBV), hepatitis C (HCV) and tuberculosis (TB) due to overlapping risk factors. Testing for viral hepatitis is not widely recommended for patients with TB. The aim of this systematic review was to evaluate the glo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Olaru, Ioana D. (VerfasserIn) , Meier, Mina Beliz (VerfasserIn) , Mirzayev, Fuad (VerfasserIn) , Prodanovic, Nevena (VerfasserIn) , Kitchen, Philip J. (VerfasserIn) , Schumacher, Samuel G. (VerfasserIn) , Denkinger, Claudia M. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 6 April 2023
In: EClinicalMedicine
Year: 2023, Jahrgang: 58, Pages: 1-11
ISSN:2589-5370
DOI:10.1016/j.eclinm.2023.101938
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.eclinm.2023.101938
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2589537023001153
Volltext
Verfasserangaben:Ioana D. Olaru, Mina Beliz Meier, Fuad Mirzayev, Nevena Prodanovic, Philip J. Kitchen, Samuel G. Schumacher, and Claudia M. Denkinger

MARC

LEADER 00000caa a2200000 c 4500
001 1854315714
003 DE-627
005 20250212130603.0
007 cr uuu---uuuuu
008 230804s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.eclinm.2023.101938  |2 doi 
035 |a (DE-627)1854315714 
035 |a (DE-599)KXP1854315714 
035 |a (OCoLC)1425213550 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Olaru, Ioana D.  |e VerfasserIn  |0 (DE-588)1248789490  |0 (DE-627)1784824372  |4 aut 
245 1 0 |a Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease  |b systematic review and meta-analysis  |c Ioana D. Olaru, Mina Beliz Meier, Fuad Mirzayev, Nevena Prodanovic, Philip J. Kitchen, Samuel G. Schumacher, and Claudia M. Denkinger 
264 1 |c 6 April 2023 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.08.2023 
520 |a Background - There is a substantial overlap in the epidemiology of chronic hepatitis B (HBV), hepatitis C (HCV) and tuberculosis (TB) due to overlapping risk factors. Testing for viral hepatitis is not widely recommended for patients with TB. The aim of this systematic review was to evaluate the global prevalence of chronic viral hepatitis infection among patients with TB. - Methods - MEDLINE, EMBASE, Web of Science, Cochrane Library, African Journals Online, LILACS, and country TB reports were searched for studies published between January 1st, 2011 and June 17th 2021. Random-effects meta-analyses for proportions were conducted to obtain pooled prevalences. The prevalence of chronic HBV/HCV infection among patients with TB was also compared to that in the general population. The protocol was registered on PROSPERO (CRD42021276468). - Findings - This analysis included 127 studies (83 for both HBV and HCV, 28 for HBV only, and 25 for HCV only) and data from 94,936 patients. The global pooled seroprevalence was 5.8% (95% CI 5.0-6.8) for HBs-antigen and 10.3% (95% CI 8.4-12.3) for HCV-antibodies. Pooled prevalence was highest in the WHO African Region for HBV at 7.8% (95% CI 5.2-10.9) and in the WHO European Region at 17.5% (95% CI 12.2-23.5) for HCV. In studies among TB patients who inject drugs, HCV prevalence was 92.5% (95% CI 80.8-99.0). Pooled HCV-antibody seroprevalence among patients with TB was higher than in the general population in all six WHO regions while HBs-antigen seroprevalence was higher in 3/6 regions. - Interpretation - This review highlights the syndemicity of chronic viral hepatitis and TB and suggests that routine testing for hepatitis upon TB diagnosis may be justified. The prevalence of chronic HBV and HCV infections was higher among patients with TB than in the general population. - Funding - This study was study was funded by the Global Tuberculosis Programme, World Health Organization. 
650 4 |a HBV 
650 4 |a HCV 
650 4 |a MDR-TB 
650 4 |a PWID 
650 4 |a Tuberculosis 
700 1 |a Meier, Mina Beliz  |d 1997-  |e VerfasserIn  |0 (DE-588)1353444120  |0 (DE-627)1914755251  |4 aut 
700 1 |a Mirzayev, Fuad  |e VerfasserIn  |4 aut 
700 1 |a Prodanovic, Nevena  |e VerfasserIn  |4 aut 
700 1 |a Kitchen, Philip J.  |e VerfasserIn  |4 aut 
700 1 |a Schumacher, Samuel G.  |e VerfasserIn  |4 aut 
700 1 |a Denkinger, Claudia M.  |d 1978-  |e VerfasserIn  |0 (DE-588)131597701  |0 (DE-627)511279469  |0 (DE-576)298613727  |4 aut 
773 0 8 |i Enthalten in  |t EClinicalMedicine  |d Amsterdam : Elsevier, 2018  |g 58(2023) vom: Apr., Artikel-ID 101938, Seite 1-11  |h Online-Ressource  |w (DE-627)1035271834  |w (DE-600)2946413-4  |w (DE-576)512181683  |x 2589-5370  |7 nnas  |a Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease systematic review and meta-analysis 
773 1 8 |g volume:58  |g year:2023  |g month:04  |g elocationid:101938  |g pages:1-11  |g extent:11  |a Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease systematic review and meta-analysis 
856 4 0 |u https://doi.org/10.1016/j.eclinm.2023.101938  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2589537023001153  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230804 
993 |a Article 
994 |a 2023 
998 |g 131597701  |a Denkinger, Claudia M.  |m 131597701:Denkinger, Claudia M.  |d 910000  |d 911700  |d 50000  |e 910000PD131597701  |e 911700PD131597701  |e 50000PD131597701  |k 0/910000/  |k 1/910000/911700/  |k 0/50000/  |p 7  |y j 
998 |g 1353444120  |a Meier, Mina Beliz  |m 1353444120:Meier, Mina Beliz  |d 50000  |e 50000PM1353444120  |k 0/50000/  |p 2 
999 |a KXP-PPN1854315714  |e 4363008687 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Ioana D. Olaru, Mina Beliz Meier, Fuad Mirzayev, Nevena Prodanovic, Philip J. Kitchen, Samuel G. Schumacher, and Claudia M. Denkinger"]},"id":{"eki":["1854315714"],"doi":["10.1016/j.eclinm.2023.101938"]},"origin":[{"dateIssuedDisp":"6 April 2023","dateIssuedKey":"2023"}],"person":[{"family":"Olaru","role":"aut","given":"Ioana D.","display":"Olaru, Ioana D."},{"family":"Meier","role":"aut","given":"Mina Beliz","display":"Meier, Mina Beliz"},{"role":"aut","given":"Fuad","family":"Mirzayev","display":"Mirzayev, Fuad"},{"family":"Prodanovic","role":"aut","given":"Nevena","display":"Prodanovic, Nevena"},{"display":"Kitchen, Philip J.","role":"aut","given":"Philip J.","family":"Kitchen"},{"display":"Schumacher, Samuel G.","given":"Samuel G.","role":"aut","family":"Schumacher"},{"role":"aut","given":"Claudia M.","family":"Denkinger","display":"Denkinger, Claudia M."}],"relHost":[{"disp":"Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease systematic review and meta-analysisEClinicalMedicine","physDesc":[{"extent":"Online-Ressource"}],"recId":"1035271834","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"note":["Gesehen am 28.05.2020"],"id":{"zdb":["2946413-4"],"eki":["1035271834"],"issn":["2589-5370"]},"part":{"year":"2023","pages":"1-11","extent":"11","text":"58(2023) vom: Apr., Artikel-ID 101938, Seite 1-11","volume":"58"},"title":[{"title_sort":"EClinicalMedicine","title":"EClinicalMedicine"}],"origin":[{"publisher":"Elsevier","publisherPlace":"Amsterdam","dateIssuedDisp":"[2018]-"}],"pubHistory":["Volume 1 (July 2018)-"]}],"title":[{"title_sort":"Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease","title":"Global prevalence of hepatitis B or hepatitis C infection among patients with tuberculosis disease","subtitle":"systematic review and meta-analysis"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 04.08.2023"],"recId":"1854315714","physDesc":[{"extent":"11 S."}]} 
SRT |a OLARUIOANAGLOBALPREV6202